Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
about
CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma.The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.Anti-fibrotic actions of relaxin.Novel Anti-fibrotic Therapies.Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin).Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
P2860
Q33645927-68B6B073-4925-435F-B897-2D59A2F41DE7Q36749450-CEE504C1-8E89-4A61-B345-A48D5F7DC488Q36941251-4564E23A-2E61-4564-B15F-341D7466DEC7Q38850557-2769F23E-4524-4781-AA8E-BBFC5C96610EQ39377055-762DAA24-ECD8-4628-A932-854FE8E0FB2BQ40940984-9FD0F9C4-B016-4D0D-975F-025B910DD131Q51534835-2F782DBF-44F0-4147-B6AA-4BAB834F2BDEQ52316713-1DAC3CAF-CD25-42A8-8D5F-1C6F80D1E168
P2860
Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Intranasally administered sere ...... s in allergic airways disease.
@en
Intranasally administered sere ...... s in allergic airways disease.
@nl
type
label
Intranasally administered sere ...... s in allergic airways disease.
@en
Intranasally administered sere ...... s in allergic airways disease.
@nl
prefLabel
Intranasally administered sere ...... s in allergic airways disease.
@en
Intranasally administered sere ...... s in allergic airways disease.
@nl
P2093
P2860
P356
P1476
Intranasally administered sere ...... s in allergic airways disease.
@en
P2093
P2860
P304
P356
10.1111/CEA.12391
P577
2014-11-01T00:00:00Z